Literature DB >> 16328407

Confirmation of mucin in lymphatic vessels of acquired cholesteatoma.

Tomoyuki Nagai1, Tatsuo Suganuma, Soyuki Ide, Hiroshi Shimoda, Seiji Kato.   

Abstract

Abundant inflammatory cells infiltrate in the advancing front of the cholesteatoma perimatrix towards the middle ear mucosa. However, the cause of inflammation is not yet clear. The middle ear mucosa is often embedded in the cholesteatoma perimatrix. We hypothesized that the embedded mucosa is the cause of inflammation. Surgical specimens obtained from 20 cases of acquired cholesteatoma were used for the study. Lymphatic vessels were stained by the immunohistochemical method using the antibody against podoplanin. Mucin was simultaneously stained by alcian blue. The results of our examination were the following: (1) the presence of infiltrating mucin in the perimatrix; (2) the degeneration and reduction of lymphatic vessels; (3) the accumulation of inflammatory cells around morbid lymphatic vessels. Based on our findings, cholesteatoma can be defined as an inflammation affected by infiltrating mucin that escaped from embedded mucosa in the perimatrix.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16328407     DOI: 10.1007/s00405-005-1012-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

1.  Stimulation of macrophages by mucins through a macrophage scavenger receptor.

Authors:  M Inoue; H Fujii; H Kaseyama; I Yamashina; H Nakada
Journal:  Biochem Biophys Res Commun       Date:  1999-10-14       Impact factor: 3.575

Review 2.  Markers for the lymphatic endothelium: in search of the holy grail?

Authors:  J P Sleeman; J Krishnan; V Kirkin; P Baumann
Journal:  Microsc Res Tech       Date:  2001-10-15       Impact factor: 2.769

3.  Long-term results of treatment for children's cholesteatoma.

Authors:  H Schmid; J C Dort; U Fisch
Journal:  Am J Otol       Date:  1991-03

4.  Cellular differentiation of the middle ear lining.

Authors:  J Sadé
Journal:  Ann Otol Rhinol Laryngol       Date:  1971-06       Impact factor: 1.547

5.  The pathology of acute and chronic infections of the middle ear cleft.

Authors:  I Friedmann
Journal:  Ann Otol Rhinol Laryngol       Date:  1971-06       Impact factor: 1.547

6.  Third place--Resident Basic Science Award 1990. Interleukin 1 causing bone destruction in middle ear cholesteatoma.

Authors:  J M Ahn; C C Huang; M Abramson
Journal:  Otolaryngol Head Neck Surg       Date:  1990-10       Impact factor: 3.497

Review 7.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

8.  Cholesteatoma. A clinical and morphological analysis.

Authors:  M Anniko; L Mendel
Journal:  Acta Otolaryngol       Date:  1981 Mar-Apr       Impact factor: 1.494

9.  Functional characterization of middle ear mucosa residues in cholesteatoma samples.

Authors:  H Sudhoff; J Bujía; A Holly; C Kim; A Fisseler-Eckhoff
Journal:  Am J Otol       Date:  1994-03

10.  Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.

Authors:  V Schilling; B Negri; J Bujía; P Schulz; E Kastenbauer
Journal:  Am J Otol       Date:  1992-07
View more
  2 in total

1.  Histopathological evaluation and long-term results of soft tissue preservation technique in cholesteatoma surgery.

Authors:  Harukazu Hiraumi; Shin-Ichi Kanemaru; Makoto Miura; Norio Yamamoto; Tatsunori Sakamoto; Juichi Ito
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-03       Impact factor: 2.503

2.  Mucosubstance histochemistry and pathogenesis of acquired cholesteatoma.

Authors:  Tomoyuki Nagai; Tatsuo Suganuma; Soyuki Ide
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-08       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.